The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Juan A De Pablo-Moreno und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Physiology and Microbiology, School of Biological Sciences, Complutense University, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Factor V, Factor V Deficiency. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association for Research and Cure of Factor V deficiency (ASDEFAV), Complutense University of Madrid and Banco Santander.
Abstract (Originalsprache)
Proteostasis, i.e., the homeostasis of proteins, responsible for ensuring protein turnover, is regulated by proteases, which also participate in the etiopathogenesis of multiple conditions. The magic of proteases is such that, in blood coagulation, one same molecule, such as coagulation factor V, for example, can perform both a procoagulant and an anticoagulant function as a result of the activity of proteases. However, this magic has an insidious side to it, as it may also prevent the completion of the clinical value chain of factor V deficiency. This value chain encompasses the discovery of knowledge, the transfer of this knowledge, and its translation to clinical practice. In the case of rare and ultra-rare diseases like factor V deficiency, this value chain has not been completed as the knowledge acquisition phase has dragged out over time, holding up the transfer of knowledge to clinical practice. The reason for this is related to the small number of patients afflicted with these conditions. As a result, new indications must be found to make the therapies cost-effective. In the case of factor V, significant research efforts have been directed at developing a recombinant factor V capable of resisting the action of the proteases capable of inactivating this factor. This is where bioethics and health equity considerations come into the equation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Physiology and Microbiology, School of Biological Sciences, Complutense University, 28040 Madrid, Spain.
ORCID-Profile: Juan A De Pablo-Moreno, Andrea Miguel-Batuecas
Förderung
- Association for Research and Cure of Factor V deficiency (ASDEFAV)
- Complutense University of Madrid and Banco Santander
Zitieren
APA
De Pablo-Moreno, J. A., Miguel-Batuecas, A., de Sancha, M., & Liras, A. (2023). The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076243
Vancouver
De Pablo-Moreno JA, Miguel-Batuecas A, de Sancha M, Liras A. The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076243
BibTeX
@article{DePabloMoreno2023,
author = {De Pablo-Moreno, Juan A and Miguel-Batuecas, Andrea and de Sancha, María and Liras, Antonio},
title = {The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076243}
}
EUVIMED